PARIS--(BUSINESS WIRE)--Biocitech, life sciences park - The biotech company Cellectis BioResearch (a subsidiary of Cellectis S.A. (Alternext: ALCLS)) today announced the market launch of a research kit for producing stable cell clones using gene targeting in just 4 weeks. The first p10® class’ product is aimed at life science researchers worldwide and is available for immediate purchase via the company's web site at www.cellectis-bioresearch.com.
